Opaleye Management Inc. - Dec 1, 2021 Form 4 Insider Report for Tracon Pharmaceuticals, Inc. (TCON)

Role
10%+ Owner
Signature
/s/ James Silverman
Stock symbol
TCON
Transactions as of
Dec 1, 2021
Transactions value $
$144,820
Form type
4
Date filed
12/3/2021, 04:14 PM
Previous filing
Nov 19, 2021
Next filing
Dec 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCON Common Stock, par value $0.001 per share Purchase $108K +45K +1.96% $2.40* 2.34M Dec 1, 2021 By Opaleye, L.P. F1
transaction TCON Common Stock, par value $0.001 per share Purchase $12K +5K +2.22% $2.40* 230K Dec 1, 2021 By Managed Account F2
transaction TCON Common Stock, par value $0.001 per share Purchase $23.5K +10K +0.43% $2.35* 2.35M Dec 2, 2021 By Opaleye, L.P. F4
transaction TCON Common Stock, par value $0.001 per share Purchase $1.17K +500 +0.22% $2.35* 231K Dec 2, 2021 By Managed Account. F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TCON Prefunded Warrants 1.89M Dec 1, 2021 Common stock 1.89M $0.01 By Opaleye, L.P. F3, F5
holding TCON Prefunded Warrants 1.36M Dec 1, 2021 Common Stock 1.36M $0.01 By Opaleye, L.P. F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased by the reporting person in open market transactions on the transaction date with a volume weighted average purchase price of $2.4032. The range of purchase prices on the transaction date was $2.33 to $2.45 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
F3 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F4 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $2.3486. The range of purchase prices on the transaction date was $2.23 to $2.39 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F5 The warrants may not be exercised to the extent that such exercise would cause the reporting person and its affiliates to beneficially own more than 9.99% of the Issuer's then outstanding common stock.